Aggressive Crosstalk Between Fatty Acids and Inflammation in Macrophages and Their Influence on Metabolic Homeostasis

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 2017 Apr 21

PMID 28424949

Citations 6

Authors

Kazuhiro Nishiyama

Yasuyuki Fujimoto

Tadayoshi Takeuchi

Yasu-Taka Azuma

Affiliations

Soon will be listed here.

Abstract

From the immunological point of view, macrophages are required to maintain metabolic homeostasis. Recently, there has been an increased focus on the influence of macrophage phenotypes in adipose tissue on the maintenance of metabolic homeostasis in healthy conditions because dysregulated metabolic homeostasis causes metabolic syndrome. This review notes several types of inflammatory and anti-inflammatory mediators in metabolic homeostasis. M1 macrophage polarization mediates inflammation, whereas M2 macrophage polarization mediates anti-inflammation. Fatty acids and their related factors mediate both inflammatory and anti-inflammatory responses. Saturated fatty acids and polyunsaturated fatty acids mediate inflammation, whereas marine-derived n-3 fatty acids, such as eicosapentaenoic acid and docosahexaenoic acid, mediate anti-inflammation. In this review, we discuss the current understanding of the crosstalk between fatty acids and inflammation in macrophages and their influence on metabolic homeostasis.

Citing Articles

Systematisation of biological protectors for managing the metabolic syndrome development.

Benberin V, Sibagatova A, Nagimtayeva A, Akhmetova K, Voshchenkova T J Diabetes Metab Disord. 2021; 20(2):1449-1454.

PMID: 34900796 PMC: 8630288. DOI: 10.1007/s40200-021-00883-3.

Nutrigenomics of Dietary Lipids.

Bordoni L, Petracci I, Zhao F, Min W, Pierella E, Assmann T Antioxidants (Basel). 2021; 10(7).

PMID: 34206632 PMC: 8300813. DOI: 10.3390/antiox10070994.

Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.

Cakici N, Sutterland A, Penninx B, de Haan L, van Beveren N Psychol Med. 2021; 51(4):538-549.

PMID: 33653423 PMC: 8020491. DOI: 10.1017/S0033291721000155.

Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases.

Yu L, Li Y, Du C, Zhao W, Zhang H, Yang Y Mediators Inflamm. 2019; 2019:5271295.

PMID: 31582899 PMC: 6754942. DOI: 10.1155/2019/5271295.

Acute high-fat feeding leads to disruptions in glucose homeostasis and worsens stroke outcome.

Haley M, Krishnan S, Burrows D, de Hoog L, Thakrar J, Schiessl I J Cereb Blood Flow Metab. 2017; 39(6):1026-1037.

PMID: 29171775 PMC: 6545621. DOI: 10.1177/0271678X17744718.

References

Talukdar S, Olefsky J, Osborn O . Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol Sci. 2011; 32(9):543-50. PMC: 3419590. DOI: 10.1016/j.tips.2011.04.004. View

Li Y, Yan H, Zhang Z, Zhang G, Sun Y, Yu P . Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway. Br J Pharmacol. 2015; 172(12):3151-8. PMC: 4459030. DOI: 10.1111/bph.13118. View

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

Han M, Jung D, Morel C, Lakhani S, Kim J, Flavell R . JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science. 2012; 339(6116):218-22. PMC: 3835653. DOI: 10.1126/science.1227568. View

Zhang Y, Li Q, Rao E, Sun Y, Grossmann M, Morris R . Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet. Immunity. 2015; 42(5):953-964. PMC: 4440244. DOI: 10.1016/j.immuni.2015.04.016. View

Lucas K, Maes M . Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Mol Neurobiol. 2013; 48(1):190-204. PMC: 7091222. DOI: 10.1007/s12035-013-8425-7. View

Meigs J, Wilson P, Nathan D, DAgostino Sr R, Williams K, Haffner S . Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003; 52(8):2160-7. DOI: 10.2337/diabetes.52.8.2160. View

Moore S, Holt V, Malpass L, Hines I, Wheeler M . Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages. Mol Immunol. 2015; 67(2 Pt B):265-75. PMC: 4565774. DOI: 10.1016/j.molimm.2015.06.001. View

10.

Bhargava P, Lee C . Role and function of macrophages in the metabolic syndrome. Biochem J. 2012; 442(2):253-62. DOI: 10.1042/BJ20111708. View

11.

Krishnan S, Dowling J, Ling Y, Diep H, Chan C, Ferens D . Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice. Br J Pharmacol. 2015; 173(4):752-65. PMC: 4742291. DOI: 10.1111/bph.13230. View

12.

Itoh M, Suganami T, Nakagawa N, Tanaka M, Yamamoto Y, Kamei Y . Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am J Pathol. 2011; 179(5):2454-63. PMC: 3204024. DOI: 10.1016/j.ajpath.2011.07.014. View

13.

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View

14.

Neuschwander-Tetri B . Fatty liver and the metabolic syndrome. Curr Opin Gastroenterol. 2007; 23(2):193-8. DOI: 10.1097/MOG.0b013e32801421a9. View

15.

Morrison M, Mulder P, Salic K, Verheij J, Liang W, van Duyvenvoorde W . Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice. Int J Obes (Lond). 2016; 40(9):1416-23. PMC: 5022108. DOI: 10.1038/ijo.2016.74. View

16.

Lumeng C, Bodzin J, Saltiel A . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007; 117(1):175-84. PMC: 1716210. DOI: 10.1172/JCI29881. View

17.

von Schacky C . Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2007; 10(2):129-35. DOI: 10.1097/MCO.0b013e3280127af0. View

18.

Hotamisligil G, Johnson R, Distel R, Ellis R, Papaioannou V, Spiegelman B . Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996; 274(5291):1377-9. DOI: 10.1126/science.274.5291.1377. View

19.

Alberti K, Zimmet P, Shaw J . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-8. View

20.

Desvergne B, Wahli W . Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999; 20(5):649-88. DOI: 10.1210/edrv.20.5.0380. View